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The innate immune response, in addition to the B- and T-cell response, plays a role in
protection against dengue virus (DENV) infection and the degree of disease severity. Early
activation of natural killer (NK) cells and type-I interferon-dependent immunity may be impor-
tant in limiting viral replication during the early stages of DENV infection and thus reducing
subsequent pathogenesis. NK cells may also produce cytokines that reduce inflammation
and tissue injury. On the other hand, NK cells are also capable of inducing liver injury
at early-time points of DENV infection. In vitro, NK cells can kill antibody-coated DENV-
infected cells through antibody-dependent cell-mediated cytotoxicity. In addition, NK cells
may directly recognize DENV-infected cells through their activating receptors, although the
increase in HLA class I expression may allow infected cells to escape the NK response.
Recently, genome-wide association studies have shown an association between MICB and
MICA, which encode ligands of the activating NK receptor NKG2D, and dengue disease
outcome.This review focuses on recognition of DENV-infected cells by NK cells and on the
regulation of expression of NK cell ligands by DENV.
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INTRODUCTION
Dengue is a major public health problem in tropical and subtrop-
ical regions world wide and is caused by four serotypes of dengue
virus (DENV-1, -2, -3, -4), a flavivirus transmitted to humans by
Aedes mosquitoes (1). DENV infection can be asymptomatic or
induce mild to severe disease, traditionally referred to as dengue
hemorrhagic fever/dengue shock syndrome (DHF/DSS), which
can lead to death (2). While there have been important advances
in elucidating dengue pathogenesis, it is difficult to foretell if an
acutely infected individual will develop the disease and to predict
its severity; however, disease outcome appears to depend on the
virus as well as on host genetics and prior immunity (3–5). For
this reason, it is crucial to understand the immune response dur-
ing DENV infection. Many studies have focused on the adaptive
response, as antibodies and T cells play a crucial role in protec-
tion against infection, as well as in the pathogenesis of dengue
disease (4–6). The innate immune response plays an intrinsic role
at the level of the infected cell (7), but also recruits and acti-
vates innate immune cells that can eliminate the virus at early
stages and induce the development of the adaptive response (8, 9).
Indeed, the extent of DENV replication during the early period
of infection correlates with dengue disease severity (10–14). Inter-
stitial dendritic cells (DCs) are believed to constitute the first line
of host defense against invading DENV at the anatomical sites
where it replicates after the initial bite by infected mosquitoes (8).
Type-I interferon-dependent immunity is known to play a critical
role, and early activation of natural killer (NK) cells may also be
important in limiting viral replication at the early stages of DENV
infection (6, 8).
NK CELLS IN VIRAL INFECTIONS
Natural killer cells are innate lymphocytes specialized in defense
against viral and intracellular bacterial infections and tumors (15).
NK cells share some characteristics with the adaptive immune
system and may possess specific memory features against some
viruses and antigens (16). They can be rapidly recruited into
infected organs and tissues by chemoattractant factors produced
by virus-infected cells and activated resident macrophages and
DCs, which are a major source of the interferon IFNα/β that
induces NK cell proliferation and activation (17, 18). Recipro-
cally, NK cells can shape DCs activation and subsequently the
adaptive response (17). Once activated, NK cells fight infection
by producing chemokines and anti-viral cytokines, mainly IFNγ
and MIP1-β, and by recognizing and eliminating infected cells
by antibody-dependent cell-mediated cytotoxicity (ADCC) or by
direct recognition through their activating receptors (15). NK
cells have activating and inhibitory receptors that allow them
to recognize stressed cells, tumors, and pathogen-infected cells
and to differentiate them from healthy cells (15, 19). Most of the
inhibitory receptors recognize classic and non-classic major his-
tocompatibility complex class I (MHC I) molecules, and many
viruses decrease the expression of MHC I molecules in infected
cells to escape the CD8+ T-cell response, thereby becoming more
vulnerable to NK cell recognition (19–21).
Virus-infected cells often induce or increase the expression of
ligands at their surface, allowing for recognition by NK cell acti-
vating receptors, including NKG2D, DNAM-1, CD94-NKG2C; the
NCR receptors NKp46, NKp30, NKp44; and others (19, 20, 22).
The ligands include host stress-induced molecules and viral
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Table 1 | Summary of the published findings related to ligands for receptors on NK cells and dengue virus infection.
Ligand Study type Observation Receptor on
NK cells
Probable effect Reference
ICAM-1 Acute patients’
lymphocytes
Adhesion molecules (ICAM-1 and
LFA-1) are increased in NK cells in the
acute phase of dengue disease
LFA-1 adhesion Azeredo et al. (31)
DENV-specific
antibodies
In vitro with activated
peripheral blood
lymphocytes
NK cells are the principal cells active in
the ADCC against DENV-infected cells
CD16 Activation, ADCC Kurane et al. (42, 43)
and Laoprasopwattana
et al. (44)
DENV ligands
(probably:
protein E)
In vitro activation of NK
cell toward E protein
and VLP of flaviviruses
Protein–protein interaction between
rNKp44 and cells expressing DENV-E
proteins. Interaction of NKp44 with E
from another flavivirus (WNV) induces
killing and IFNγ production
NKp44 Activation? Hershkovitz et al. (55)
MICA Allele association MICA alleles associated with dengue
symptomatic infection
NKG2D Activation? García et al. (59)
MICB Allele association,
GWAS
MICB alleles associated with
symptomatic infection and dengue
shock syndrome
NKG2D Activation? García et al. (59), Khor
et al. (60), Whitehorn
et al. (61)
proteins (20). To date, the ligands for many of the activating
receptors (for example the NCRs) are still unknown, and their
expression has been detected indirectly by cell staining with recom-
binant receptors or by blocking of killing with receptor-specific
antibodies. A better characterization of NK ligands is needed.
NKG2D is the most well-characterized NK activating receptor,
and ligand binding leads to target killing and cytokine production
(22). NKG2D ligand expression is increased by “stress” condi-
tions, including viral infections (22, 23). In humans, eight ligands
have been described for NKG2D, including MICA, MICB, and
ULBP1-6. In addition to expression of NKG2D ligands on the
surface of infected cells, soluble isoforms can be released into the
serum, although the physiological relevance of the soluble ligands
is controversial (22, 24). These soluble forms have been described
in cancer patients, as well as in HIV-1-infected patients without
therapy (25, 26) suggesting that soluble NKG2D ligands might be
released in other viral infections.
ROLE OF NK CELLS IN DENGUE DISEASE
Many studies suggest that NK cells play a role in the response
against DENV infection, principally in the early infection stages by
limiting DENV replication. A higher absolute number of NK cells
was observed in patients with mild dengue fever (DF) compared
with children who developed DHF (27–29). However, the percent-
age of NK cells and CD8+ T cells expressing CD69, a marker of
activation,was higher early during infection of children who devel-
oped DHF (27, 30). Homchampa et al. found evidence of NK cell
cytotoxicity against non-infected K562 target cells from children
with acute dengue, and the cytolytic activity was increased on a
per-cell basis in the early disease stages of dengue compared with
healthy controls, and was even higher in the most severe form of
the disease. It was suggested that this NK cell activity was asso-
ciated with higher viremia in the more severe cases. Studies in
adults showed that patients with mild disease had higher numbers
of NK cells, with the majority of cells having increased expression
of activation markers (CD69, CD38, and HLA-DR), adhesion mol-
ecules (CD11a and CD44) (Table 1), and markers of intracellular
cytotoxic granules (TIA-1), in contrast to severe dengue where
reduced NK cell numbers were observed (31). The authors suggest
that higher NK cell percentages and activity might indicate a good
prognosis of disease. In a genome-wide association study (GWAS),
it was shown that the transcriptome of blood cells from children
with DSS was characterized by decreased abundance of transcripts
related to T and NK responses, probably not due to a difference
in lymphocyte counts but to an impaired response (32). The dif-
ferences observed in NK cell numbers and percentages in these
studies may be explained by differences in age (children versus
adults), ethnicity, time of infection, and the experimental meth-
ods to define NK cells and their activation. Nonetheless, all these
observations point to the importance of NK cells and their activa-
tion during early DENV infection. The activation and phenotype
of NK cells during dengue acute infection is further developed by
Petitdemange et al., under the research topic “protective immune
response to dengue virus infection and vaccines: perspectives from
the field to the bench.”
The protective role of NK cells in the response against DENV
is supported in mice models of the disease. In immunocompetent
A/J mice, the early activation of NK and B cells was associated with
the control of the viral load and the prevention of disease (33, 34).
In C57BL/6 mice, the recruitment of NK and NKT cells by mast
cells to the site of infection was also crucial for viral clearance
(35), underlining the importance of these cells during the host
early response against DENV. The early recruitment of NK cells to
the liver was induced in part by CXCL10 (IP-10), and in the liver
NK cells produce effector molecules (perforin, granzyme A, and
granzyme B) needed for viral clearance (36). On the other hand,
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NK cells appear to play not only a protective role in dengue dis-
ease, as it was shown that after intrahepatic infiltration, NK cells
were responsible for cell death in the liver at the early phase of
infection, whereas CD8+ T cells were responsible for damage later
(37). The mechanism of this cell death has not been elucidated,
but the authors suggested that NK cells were killing DENV-infected
cells. It is possible that under some conditions, the elimination of
DENV-infected cells by NK cells can be exacerbated in a way that
the immune effector cells become responsible for organ injury.
Similarly, NKT cells in some conditions can be detrimental during
dengue pathogenesis, in part by inducing NK cells and neutrophils
activation (38).
Natural killer cells may play an important role in early DENV
infection in vivo also by producing together with γδ T cells, IL-22
and IL-17A, which may influence dengue disease outcome (39).
NK, NKT, and T cells that can respond in a non-TcR-dependent
fashion are a major source of IFNγ in immune responses induced
by inactivated DENV (40); however, in this context, the frequency
of IFNγ-producing cells observed was very low. Using C57BL/6
mice, a study confirmed the role of NK cells in the early IFNγ pro-
duction induced by IL-12 and IL-18 in response to DENV, key for
the control of viral load and DENV-2-associated disease severity
and lethality (41).
Natural killer cells can mediate ADCC against DENV-infected
cells (42, 43) and this mechanism may be important during sec-
ondary infections when antibodies to DENV are present. Indeed,
ADCC activity in plasma obtained before secondary DENV-2 or
DENV-3 infection correlated with serotype-specific neutralizing
antibody titers, anti-DENV IgG1 levels, and a multitypic PRNT50
pattern (44). Interestingly, a higher level of ADCC activity mea-
sured before secondary DENV-3 infection was associated with
lower subsequent viremia, which suggests a protective role for anti-
bodies and NK cells; however, this association was not observed
for secondary DENV-2 infection. In another study,ADCC was cor-
related with DENV surface antigen expression, suggesting recog-
nition by anti-DENV antibodies (42), whose Fc region is then
recognized by the activating low affinity CD16 (FcγRIII) receptor
on NK cells (45).
Human NK cells (CD3−CD16+CD11b+ cells) can lyse DENV-
infected cells to a greater level than uninfected cells even in the
absence of antibodies, suggesting a mechanism of direct recogni-
tion as well (42, 43). These studies were performed using DENV-
infected Raji cells as targets. The NK receptors and their ligands
implicated in the direct recognition of DENV-infected cells have
not been fully elucidated, indicating the need for future studies.
EXPRESSION OF NK CELL LIGANDS DURING DENGUE
DISEASE
Viruses try to escape the immune response of the host. As NK
cells are crucial players in the anti-viral response, many viruses
induce the up-regulation of MHC I, which serve as ligands for NK
inhibitory receptors, in order to dampen the NK cell response
even if enhancing expression of MHC I might increase their
recognition by CD8+ T cells (20). DENV and other flaviviruses
induce the up-regulation of MHC I (46–51). Expression of fla-
vivirus pr-M protein in hamster cells induced increased surface
expression of MHC I, although the authors suggested this could
be an incidental consequence of viral assembly rather than a spe-
cific mechanism of immune evasion (52). It has also been shown
that human cell lines expressing the non-structural (NS) pro-
teins of DENV up-regulate MHC I (HLA-A, -B, -C) expression
at their surface by TAP-dependent and TAP-independent path-
ways (46). This resulted in a lower sensibility to lysis by NK
cells, probably due to recognition by the corresponding inhibitory
receptors (e.g., KIR2DL1 for HLA-C) and the inhibitory receptor
LIR-1 that recognizes all MHC I proteins (Table 1). Further stud-
ies are needed to determine if MHC I up-regulation by DENV
is the response to a particular viral protein, viral replication
itself, or type-I IFNs induced by viral infection, and whether
it plays a role in immune evasion of NK cells in vivo. Neu-
rotropic flaviviruses, such as West Nile virus (WNV), can tran-
siently activate and then suppress NK cell activity (53). Future
studies are needed to determine if this happens during DENV
infection by analyzing NK cell activity at different time points
post-infection.
Even if DENV NS proteins induce MHC I up-regulation, NK
cells can kill DENV-infected cells (28, 42, 43), suggesting that the
signals for NK cell activation overcome the inhibitory signals. As
described above, NK cells can kill DENV-infected cells by ADCC
mediated by CD16 (42, 44) (Table 1), which is expressed on resting
human NK cells and can induce a strong activating signal leading
to cytolysis (20, 54). Interestingly, NK cells can also kill DENV-
infected cells in the absence of antibodies (42), implicating a direct
recognition by NK cell activating receptors. It has been reported
that the activating receptor NKp44 can interact with the envelope
protein (E) of DENV (55) (Table 1). NKp44 has also been impli-
cated in killing WNV-infected cells after blocking the inhibitory
receptor LIR-1 on NK cells, and this also induced IFNγ produc-
tion. Further studies are necessary to determine if recognition of
DENV-E by NKp44 on NK cells can induce a similar response
against DENV-infected cells. NKp44 is expressed on activated, but
not resting, NK cells (56) and can trigger NK cell killing of both
tumor and virus-infected cells (57, 58).
Recently, a sequencing-based typing method and genotyping of
asymptomatic DF and DHF patients in Cuba uncovered an associ-
ation of certain alleles of the MICA and MICB genes (MICA*008
and MICB*008) with symptomatic DENV infection (59) (Table 1).
The importance of MICB in dengue susceptibility was also indi-
cated by GWAS with a large number of pediatric cases in Vietnam,
where certain MICB and PLCE1 alleles showed a significant asso-
ciation with DSS (60). These results were confirmed by a study
showing that MICB rs3132468 and PLCE1 risk genotypes were
also associated with less severe clinical phenotypes of dengue
in adults as well as with DENV infection in infants (61). This
strongly suggests a role for this MICB variant in susceptibility
to overall clinically apparent dengue disease. It still has not been
determined whether the association between these NKG2D lig-
ands and dengue clinical responses is directly due to the function
of MICA/B molecules in dengue pathogenesis. Nonetheless, the
importance of NKG2D ligands in the NK cell response against
other viral infections (22) supports this hypothesis. Given the role
of MICB in activation of NK, NKT, and CD8+ T cells through
the NKG2D receptor, these findings support a central role for
these cell types in shaping the outcome of DENV infection. It
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FIGURE 1 | Schematic model of NK cells interaction with DENV-infected
cells. NK cells recognize infected cells through the interaction of their
receptors with ligands on the infected cells, the outcome depends on the
balance between activating or inhibitory signals. Once activated NK cells are
capable of ADCC or direct cytotoxicity, and of producing cytokines, mainly
IFNγ.
is plausible that the MICB risk-associated phenotype is associ-
ated with an impaired NK cell response, potentially resulting in a
higher in vivo virus titer and an increased risk of developing both
symptomatic and severe dengue. Furthermore, inefficient induc-
tion of cytokines secreted by NK cells might result in dysregulated
T-cell responses that may also shape the clinical phenotype (62).
NKG2D ligand (MICA/B) expression on DENV-infected cells may
allow direct recognition by NK cells, which might be important for
the early innate immune response against DENV infection, leading
to either more effective control of viral infection or alternatively
contributing to the disease pathology. The expression pattern of
these NKG2D ligands in DENV-infected cells in vitro and in vivo
needs to be determined. It is also necessary to determine if in acute
viral infections such as DENV, the production of soluble NKG2D
ligands can also be observed and if this impacts dengue clinical
manifestations. Because ligands of other NK activating receptors,
such as DNAM-1, can be induced by “stress” (23), further studies
are needed to characterize all the NK receptor ligands induced dur-
ing DENV infection, and the results may depend on the cell-type
analyzed, as well as the DENV serotype. A complete characteriza-
tion of DENV-infected cell recognition by NK cells (Figure 1) is
crucial to better understanding the role of these cells in dengue
disease.
CONCLUSION
The innate immune response, and particularly type-I IFN and
NK cells, plays a key role during the early infection events due
to its ability to rapidly limit viral dissemination and to affect the
antigen-specific, adaptive immune responses to effectively clear
pathogens (8, 9). More studies in animal models and human
populations will enable deciphering NK cell responses during
DENV infection in vivo. Furthermore, in vitro experiments will
also be needed to determine which NK receptors and ligands
are implicated in DENV-infected cell recognition and NK cell-
mediated killing and cytokine production. To date, only the up-
regulation of MHC I and the induction of a putative NKp44 ligand
(DENV-E protein) have been reported in DENV-infected cells. Are
there other ligands that play a role in NK cell recognition induced
during DENV infection? Genetic studies suggest an important
role for the NKG2D ligands MICA and MICB; however, as yet
no functional experiments have validated this hypothesis. There
is still much to do to determine if ligands of other NK recep-
tors, for example HLA-E for CD94/NKG2A-C and the ligands
for the activating receptors 2B4 and DNAM-1, are induced or
repressed during DENV infection, and whether this has an impli-
cation in the immune response to DENV and its clinical outcome.
Finally, the characterization of NK receptor ligands and the NK
cell phenotype in patients’ blood cells will provide insights into
the NK cell subsets activated during dengue disease. It will also
establish possible associations between NK cell activity or NK cell
ligand expression and protection from disease and/or increased
dengue severity. Whether DENV interferes with innate anti-viral
immunity mediated by NK cells at early times of infection and
whether DENV virulence might be associated with its ability to
counter the host cell defenses are critical issues that remain to be
elucidated.
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